Blujepa (Gepotidacin)

Medical Uses: Blujepa (gepotidacin) is a triazaacenaphthylene bacterial type II topoisomerase inhibitor used for the treatment of female adult and pediatric patients aged 12 years and older weighing at least 40 kilograms (kg) with uncomplicated urinary tract infections (uUTI) caused by the following susceptible microorganisms: Escherichia coli, Klebsiella pneumoniae, Staphylococcus saprophyticus, Citrobacter freundii complex, and Enterococcus faecalis.

Note: To reduce the development of drug-resistant bacteria and maintain the effectiveness of Blujepa and other antibacterial medicines, Blujepa must be used only to treat infections that are proven or strongly suspected to be caused by bacteria.

Recommended Dosage:
The recommended dosage of Blujepa is 1,500 mg (two 750 mg tablets) taken orally (by mouth), twice daily (approximately 12 hours apart) for 5 days. Administer the prescribed dosage after a meal to reduce the possibility of gastrointestinal intolerance.
If a dose is skipped or missed, instruct patients to take the skipped/missed dose as quickly as possible. It is not advisable to double the dose to make up for a skipped/missed dose.

• Treatment with Gepotidacin 750 mg tablets may alter a patient’s heart rhythm by extending the QT interval. Patients having heart issues or taking other drugs that can prolong the QT segment should be observed. In case of unexplained loss of consciousness or peculiar heartbeat, inform the physician immediately.
• Acetylcholinesterase activity may be mildly inhibited, which causes an increase in the amount of acetylcholine in the nervous system. Such patients may include those currently suffering from neurological disorders, like myasthenia gravis, that require caution. You should tell your physician in case you develop symptoms like muscle weakness, breathing trouble, or drooping eyelids.
• Other side effects associated with Gepotidacin may include allergic sore throat with a rash, breathing difficulty, however, these reactions are rare. Patients noticing any symptoms that point out the need to use hypodermic medication should seek medical advice immediately. Patients previously having allergy-related ailments should consult with their doctor in advance.
• Like other antibiotics, gepotidacin may alter the balance of normal flora of the intestine and possibly cause C. difficile infection. Patients should be alert for symptoms such as diarrhea, pain in the abdomen, or fever. Consult with a physician if such symptoms arise during or after treatment. Some severe cases may need other treatment in addition to standard therapy.
• There is an increased risk of developing resistant strains of bacteria if Gepotidacin is misused or used unnecessarily. It is essential to complete the therapy as recommended, even if symptoms improve significantly. To sustain the efficacy of the medication, do not give it to others.
• The possible outcomes from using Gepotidacin 750 mg during pregnancy are not well established. Women should take this medication only when absolutely necessary, and only if a qualified physician has given a proper diagnosis. Talk about what could go wrong and what could go right during the pregnancy and after conception, before starting treatment during pregnancy.
• It has not been determined whether or not Gepotidacin transfers into breast milk. Mothers with infants should get a proper consultation before taking this medicine. If they have a prescription, observe young children for any symptoms of negative reactions alongside or instead of hyperactivity, decreased appetite, and unexpected increase in aggressive behavior.

What documents are required to import BLUJEPA to India?

BLUJEPA (gepotidacin) tablets can be imported by patients or government hospitals in the patients' name only.

• The following documentation is required to import the product:
• A valid prescription from a qualified doctor.
• Patients diagnostic reports
• Patient ID proof (issued by the government of India)

How does the order get confirmed?

The order will be confirmed only after the receipt of:

• A valid prescription from the Doctor
• Import permit if applicable

Is BLUJEPA available in India?

BLUJEPA (gepotidacin tablets) is a (prescription drug, prescription medication, or prescription medicine) pharmaceutical drug that legally requires a medical prescription to be dispensed.

IPN (Indian Pharma Network) helps import cancer medicines on the named patient supply (NPS). Indian Pharma Network is the facilitator, providing input

• On availability of Blujepa in India (Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Pune, etc.)
• On availability in Gulf countries (Bahrain, Oman, Qatar, Kuwait, Iraq, Saudi Arabia, and the UAE).
• Medicine Price.
• Finding Genuine and reliable sources from the USA, Canada, Europe, and Australia
• Ensuring 100% transparency.

BLUJEPA can be made available to patients, doctors, and hospitals in Mumbai, Goa, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow, and Pune, and other cities in India. The order will be confirmed only after the receipt of a valid prescription from the doctor and an import permit.

IPN (Indian Pharma Network) can facilitate the supply of BLUJEPA (a prescription medicine) to all locations in the world and India after fulfilling the legal requirements (if applicable).

Please contact +91-9310090915 | Toll-Free Number: 1800-889-1064 or write us at info@indianpharmanetwork.in for Blujepa 750 mg Tablet price in India.

We guarantee quality and delivery anywhere in the world as per the buyer’s requirements.

Indian Pharma Network can source BLUJEPA (Cancer Treatment Medicines) from across the globe and can supply. Indian Pharma offers its customers worldwide access to the best available treatment.

Indian Pharma Network (IPN) can dispense any valid prescription in the shortest possible time. All prescriptions are dispensed and checked by registered pharmacists and dispatched to the Patient's address only from New Delhi, India.

What is the Generic Name for the trade name drug Blujepa®?

Gepotidacin is the Generic Name for the trade name drug Blujepa®.

What is the Manufacturer's Name of Blujepa®?

Blujepa® is manufactured by GlaxoSmithKline.

Is Blujepa® approved by the FDA?

No, Blujepa® is approved by the FDA. Date of first Approval: March 25, 2025.

What is the dosage and form of Blujepa® supplied?

Blujepa® is supplied in Tablets: 750 mg for oral administration. This oral medicine can only be obtained with a prescription.

What are the most common side effects of Blujepa® 750 mg?

The most common side effects of Blujepa® are abdominal pain, diarrhea, nausea, soft feces, flatulence, headache, dizziness, vulvovaginal candidiasis, and vomiting.

How much does the Blujepa® 750 mg Tablet cost in India?

Prices of Blujepa may fluctuate over time because of market dynamics and regulatory changes. To get the most accurate and latest details on the Blujepa 750 mg tablet cost in India, please call/WhatsApp +91-9310090915 or send mail to info@indianpharmanetwork.in.

Can Blujepa® 750 mg Tablets be available in SAARC countries?

Apart from Gulf countries, Blujepa® 750 mg can be available in SAARC countries (India, Afghanistan, Maldives, Nepal, Bangladesh, Bhutan, Pakistan, and Sri Lanka). Indian Pharma Network (IPN) can help facilitate the legal supply of Blujepa® tablets in these countries. We help ensure legal access to this therapeutic drug through our reliable channels.

Is it safe to buy Blujepa® 750 mg Tablets online in India?

Yes, one can buy Blujepa 750 mg online in India at the lowest price from the Indian Pharma Network (IPN) if this medicinal product is not (yet) registered or available in their country. We can help facilitate the supply of Blujepa® oral tablets through legal channels.

What are the storage conditions of Blujepa® 750 mg tablets?

Store the bottle of tablets at 20 to 25°C (68 to 77°F); excursions permitted between 15 and 30°C (59 and 86°F).